The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

Abstract

Analyses and comparisons of ADNI data strongly support the hypothesis that measurable change occurs in cerebrospinal fluid, positron emission tomography, and magnetic resonance imaging well in advance of the actual diagnosis of AD.